Cover Image
Market Research Report
Product code 
1062915

Orphan Drugs Global Market Report 2022

Published: Pre-Order | The Business Research Company | 400 Pages | Delivery time: 2-10 business days

Price

Back to Top
Orphan Drugs Global Market Report 2022
Published: Pre-Order
The Business Research Company
Content info: 400 Pages
Delivery time: 2-10 business days
  • Description
  • Table of Contents

“Orphan Drugs Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global orphan drugs market.

This report focuses on orphan drugs market which is experiencing strong growth. The report gives a guide to the orphan drugs market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the orphan drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Orphan Drugs market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider orphan drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The orphan drugs market section of the report gives context. It compares the orphan drugs market with other segments of the orphan drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, orphan drugs indicators comparison.

Scope

Markets Covered:

1) By Therapy Area: Oncology; Blood; Central Nervous System; Endocrine; Cardiovascular; Respiratory; Immunomodulatory

2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Sales

3) By Drug Type: Biological; Non-Biological

4) By Diesease Type: Oncology; Hematology; Neurology; Cardiovascular; Others

Companies Mentioned: Bristol-Myers Squibb Company; Celgene Corporation; F. Hoffmann-La Roche Ltd.; Amgen; Biogen

Countries: Brazil; China; France; Germany; India; Indonesia; Japan; South Korea; Russia; UK; USA; Australia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: h1137

Table of Contents

1. Executive Summary

2. Orphan Drugs Market Characteristics

3. Orphan Drugs Market Trends And Strategies

4. Impact Of COVID-19 On Orphan Drugs

5. Orphan Drugs Market Size And Growth

  • 5.1. Global Orphan Drugs Historic Market, 2016-2021, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Orphan Drugs Forecast Market, 2021-2026F, 2031F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Orphan Drugs Market Segmentation

  • 6.1. Global Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Oncology
  • Blood
  • Central Nervous System
  • Endocrine
  • Cardiovascular
  • Respiratory
  • Immunomodulatory
  • 6.2. Global Orphan Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales
  • 6.3. Global Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Biological
  • Non-Biological
  • 6.4. Global Orphan Drugs Market, Segmentation By Diesease Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Oncology
  • Hematology
  • Neurology
  • Cardiovascular
  • Others

7. Orphan Drugs Market Regional And Country Analysis

  • 7.1. Global Orphan Drugs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 7.2. Global Orphan Drugs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Orphan Drugs Market

  • 8.1. Asia-Pacific Orphan Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Orphan Drugs Market

  • 9.1. China Orphan Drugs Market Overview
  • 9.2. China Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Orphan Drugs Market

  • 10.1. India Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Orphan Drugs Market

  • 11.1. Japan Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Orphan Drugs Market

  • 12.1. Australia Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Orphan Drugs Market

  • 13.1. Indonesia Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Orphan Drugs Market

  • 14.1. South Korea Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Orphan Drugs Market

  • 15.1. Western Europe Orphan Drugs Market Overview
  • 15.2. Western Europe Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Orphan Drugs Market

  • 16.1. UK Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Orphan Drugs Market

  • 17.1. Germany Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Orphan Drugs Market

  • 18.3. France Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Orphan Drugs Market

  • 19.1. Eastern Europe Orphan Drugs Market Overview
  • 19.2. Eastern Europe Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Orphan Drugs Market

  • 20.1. Russia Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Orphan Drugs Market

  • 21.1. North America Orphan Drugs Market Overview
  • 21.2. North America Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Orphan Drugs Market

  • 22.1. USA Orphan Drugs Market Overview
  • 22.2. USA Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Orphan Drugs Market

  • 23.1. South America Orphan Drugs Market Overview
  • 23.2. South America Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Orphan Drugs Market

  • 24.1. Brazil Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Orphan Drugs Market

  • 25.1. Middle East Orphan Drugs Market Overview
  • 25.2. Middle East Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Orphan Drugs Market

  • 26.1. Africa Orphan Drugs Market Overview
  • 26.2. Africa Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Orphan Drugs Market Competitive Landscape And Company Profiles

  • 27.1. Orphan Drugs Market Competitive Landscape
  • 27.2. Orphan Drugs Market Company Profiles
    • 27.2.1. Bristol-Myers Squibb Company
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Celgene Corporation
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. F. Hoffmann-La Roche Ltd
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Amgen
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Biogen
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Orphan Drugs Pipeline Analysis

29. Key Mergers And Acquisitions In The Orphan Drugs Market

30. Orphan Drugs Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer